IP Library Granted Patent US 9,427,556
Granted Patent B2
US 9,427,556 · App. 13/306,076 · Granted Aug 30, 2016

Methods for treatment of a body cavity or lumen

Inventor: Daniel Rogers Burnett (San Francisco, CA)
Assignee: Channel Medsystems, Inc.
A61M25/10A61B18/04A61B2018/00023A61B2018/046A61M2025/0002A61M2025/0003A61M2025/0175A61M2025/1015A61M2025/1052A61M2210/105A61M2210/1433
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,427,556
App. No.
13/306,076
Granted
Aug 30, 2016
Kind
B2
Abstract

Methods and apparatus for the treatment of a body cavity or lumen are described where a heated fluid and/or gas may be introduced through a catheter and into treatment area within the body contained between one or more inflatable/expandable members. The catheter may also have optional pressure sensing elements which may allow for control of the pressure within the treatment zone and also prevent the pressure from exceeding a pressure of the inflatable/expandable members to thereby contain the treatment area between these inflatable/expandable members. Optionally, a chilled or room temperature fluid such as water may then be used to rapidly terminate the treatment session.

Claims (59)

1. A method for treating a body cavity or lumen, comprising:

positioning a tissue region of interest between a distal occlusion member and a proximal occlusion member which are adjustably movable relative to one another via adjustment of a catheter;

occluding the tissue region to be treated between the occlusion members such that a treatment area is defined therebetween;

introducing a hyperthermic or hypothermic fluid and/or gas into the treatment area such that the tissue region is treated by thermal ablation with the hyperthermic or hypothermic fluid and/or gas contacting the tissue region;

monitoring a first pressure of the hyperthermic or hypothermic fluid and/or was introduced into the treatment area;

comparing the first pressure against a second pressure within the occlusion members; and

adjusting the first pressure to be below the second pressure if the first pressure exceeds the second pressure.

2. The method of claim 1 wherein positioning comprises positioning the catheter within a body lumen selected from the group consisting of an esophagus, uterus, respiratory tract, and bladder.

3. The method of claim 1 wherein occluding the tissue region comprises inflating the occlusion members via a fluid.

4. The method of claim 1 wherein occluding the tissue region comprises expanding the occlusion members via a self-expanding or shape-memory material.

5. The method of claim 1 wherein introducing a hyperthermic or hypothermic fluid and/or gas comprises heating or cooling the fluid and/or gas prior to introduction into the treatment area.

6. The method of claim 1 further comprising visualizing via an endoscope while at least positioning.

7. The method of claim wherein the fluid and/or gas is chilled to less than −5 degrees C.

8. The method of claim 1 further comprising stirring, or circulating the fluid and/or gas within the treatment area such that temperature of the fluid and/or gas is even.

9. The method of claim 1 further comprising introducing, an additional fluid into the treatment area having a temperature which cools or warms the fluid and/or gas.

10. The method of claim 1 wherein the fluid and/or gas comprises water.

11. The method of claim 1 , wherein the hyperthermic fluid and/or gas is between 42 degrees Celsius and 100 degrees Celsius.

12. The method of claim 1 , wherein the hypothermic fluid and/or gas is between −2 degrees Celsius and −40 degrees Celsius.

13. The method of claim 1 , wherein the treatment area is exposed to the hyperthermic fluid and/or gas for a period between 15 seconds and 15 minutes.

14. The method of claim 1 , wherein the hypothermic fluid and/or was is between −5 degrees Celsius and −20 degrees Celsius.

15. A method for treating a body cavity or lumen, comprising:

positioning a tissue region of interest between a distal occlusion member and a proximal occlusion member which are adjustably movable relative to one another via adjustment of a catheter;

occluding the tissue region to be treated between the occlusion members such that a treatment area is defined therebetween;

introducing a hyperthermic or hypothermic gel or colloidal suspension into the treatment area such that the tissue region is treated by thermal ablation with the hyperthermic or hypothermic gel or colloidal suspension contacting the tissue region;

monitoring a first pressure of the hyperthermic or hypothermic gel or colloidal suspension introduced into the treatment area;

comparing the first pressure against a second pressure within the occlusion members; and

adjusting the first pressure to be below the second pressure if the first pressure exceeds the second pressure.

16. The method of claim 15 wherein the gel or colloidal suspension comprises a suspension of metal particles, fibers or ions.

17. The method of claim 15 wherein positioning comprises positioning the catheter within a body lumen selected from the group consisting of an esophagus, uterus, respiratory tract, and bladder.

18. The method of claim 15 wherein occluding the tissue region comprises inflating the occlusion members via a fluid.

19. The method of claim 15 wherein introducing a hyperthermic or hypothermic gel or colloidal suspension comprises heating or cooling the gel or colloidal suspension prior to introduction into the treatment area.

20. The method of claim 15 further comprising visualizing via an endoscope while at least positioning.

21. The method of claim 15 wherein the gel or colloidal suspension is chilled to less than −5 degrees C.

22. The method of claim 15 further comprising stirring or circulating the gel or colloidal suspension within the treatment area such that temperature of the gel or colloidal suspension is even.

23. The method of claim 15 further comprising introducing an additional fluid into the treatment area having a temperature which cools or warms the gel or colloidal suspension.

24. The method of claim 15 , wherein the hyperthermic gel or colloidal suspension is between 42 degrees Celsius and 100 degrees Celsius.

25. The method of claim 15 , wherein the hypothermic gel or colloidal suspension is between −2 degrees Celsius and −40 degrees Celsius.

26. The method of claim 15 , wherein the treatment area is exposed to the hyperthermic gel or colloidal suspension for a period between 15 seconds and 15 minutes.

27. The method of claim 15 , wherein the hypothermic gel or colloidal suspension is between −5 degrees Celsius and −20 degrees Celsius.

28. A method for treating a body cavity or lumen, comprising:

positioning a distal end of a treatment catheter within an opening of a body cavity or lumen;

occluding the opening such that fluid communication is inhibited between an outer surface of the catheter and the opening such that a treatment area is defined within the body cavity or lumen;

introducing a hyperthermic or hypothermic fluid and/or gas into the treatment area such that a tissue region in the treatment area is treated by thermal ablation with the hyperthermic or hypothermic fluid and/or gas contacting the tissue region;

monitoring a treatment pressure of the hyperthermic or hypothermic fluid and/or gas introduced into the body cavity or lumen;

comparing the treatment pressure against an occluding pressure between the catheter and opening; and

adjusting the treatment pressure to be below the occluding pressure if the treatment pressure exceeds the occluding pressure.

29. The method of claim 28 wherein positioning comprises positioning the catheter distal end within a uterus or bladder.

30. The method of claim 28 wherein occluding comprises inflating an occlusion member via a fluid in proximity to the opening.

31. The method of claim 28 wherein occluding comprises expanding an occlusion members via a self-expanding or shape-memory material.

32. The method of claim 28 wherein introducing a hyperthermic or hypothermic fluid and/or gas comprises heating or cooling the fluid and/or gas prior to introduction into the body cavity or lumen.

33. The method of claim 28 further comprising visualizing via an endoscope while at least positioning.

34. The method of claim 28 wherein the fluid and/or gas is chilled to less than −5 degrees C.

35. The method of claim 28 further comprising stirring or circulating the fluid and/or gas within the body cavity or lumen such that temperature of the fluid and/or gas is even.

36. The method of claim 28 further comprising introducing an additional fluid into the treatment area having a temperature which cools or warms the fluid and/or gas.

37. The method of claim 28 wherein the fluid and/or gas comprises water.

38. The method of claim 28 , wherein the hyperthermic fluid and/or gas is between 42 degrees Celsius and 100 degrees Celsius.

39. The method of claim 28 , wherein the hypothermic fluid and/or gas is between −2 degrees Celsius and −40 degrees Celsius.

40. The method of claim 28 , wherein the treatment area is exposed to the hyperthermic fluid and/or gas for a period between 15 seconds and 15 minutes.

41. The method of claim 28 , wherein the hypothermic fluid and/or was is between −5 degrees Celsius and −20 degrees Celsius.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2012
From: BURNETT, DANIEL ROGERS
To: CHANNEL MEDSYSTEMS, INC.
Reel/Frame 027681/0966 →
Continuity (5)
Continuation PCTUS2010036947 · Jun 1, 2010
Provisional Application 61337648 · Feb 11, 2010
Provisional Application 61277770 · Sep 30, 2009
Provisional Application 61217537 · Jun 1, 2009
Related Publication 20120136343A1 · May 31, 2012